 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper128th MAINE LEGISLATURE
FIRST REGULAR SESSION-2017
Legislative Document No. 184
H.P. 140 House of  Representatives, January 24, 2017
An Act  To Allow Hospitals To  More  Efficiently Monitor the 
Prescribing of Controlled Substances  by Amending the Laws 
Governing Access to Prescription Monitoring Information
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative MALABY of Hancock.
Cosponsored by Representatives:  CHACE of Durham, HARVELL of Farmington,  HEAD of 
Bethel, HYMANSON of York, NADEAU  of Winslow.

 
 Page 1 - 128LR0917(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  22 MRSA §7250, sub -§4, ¶¶I and J, as enacted by PL 2015, c. 488, §6, 2 
are amended to read:  3 
I.  Staff members of a licensed hospital who are authorized by the chief medical 4 
officer of the  hospital, insofar as the information relates to a patient receiving care in 5 
the hospital's emergency department or receiving inpatient services from the hospital; 6 
and 7 
J.  Staff members of a pharmacist who are authorized by the pharmacist on duty, 8 
insofar as the information relates to a customer seeking to have a prescription filled .; 9 
and 10 
Sec. 2.  22 MRSA §7250, sub -§4, ¶K is enacted to read:  11 
K.  The chief medical officer, medical director or other similar individual employed 12 
by a licensed hospital, insofar  as the information relates to prescriptions written by 13 
prescribers employed by that licensed hospital.  14 
SUMMARY  15 
The purpose of this bill is to allow a hospital to more efficiently monitor the 16 
prescribing of controlled substances by its employed prescribers  by authorizing a 17 
hospital's chief medical officer, medical director or other similar individual employed by 18 
the hospital to access prescription monitoring information.  19 
 
